| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 3.8% | $51,436,214 | 2,047,620 | Venrock Healthcare Capital Partners III, L.P. | 30 Jun 2025 | |||
| Bain Capital Life Sciences Fund, L.P. | 3% | $46,597,344 | 1,867,629 | Bain Capital Life Sciences Fund, L.P. | 30 Sep 2025 |
As of 30 Sep 2025, 83 institutional investors reported holding 57,844,608 shares of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS). This represents 93% of the company’s total 62,254,300 outstanding shares.
The largest institutional shareholders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) together control 86% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 13% | 8,031,252 | +6.6% | 6% | $200,379,737 |
| FMR LLC | 10% | 6,399,158 | +18% | 0.01% | $159,658,992 |
| Foresite Capital Management IV, LLC | 7.7% | 4,778,581 | +8.3% | 65% | $119,225,596 |
| venBio Partners LLC | 7.5% | 4,639,304 | +8.2% | 66% | $115,750,635 |
| VIKING GLOBAL INVESTORS LP | 5.9% | 3,653,310 | 0% | 0.24% | $91,150,085 |
| EQT Fund Management S.a r.l. | 5.5% | 3,424,609 | 0% | 4.6% | $85,443,995 |
| Bain Capital Life Sciences Investors, LLC | 5.1% | 3,181,275 | -3.7% | 5.3% | $79,372,811 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.9% | 2,442,464 | +21% | 0.93% | $60,939,477 |
| Commodore Capital LP | 3.9% | 2,418,476 | +27% | 2.9% | $60,340,976 |
| Paradigm Biocapital Advisors LP | 2.9% | 1,835,494 | +73% | 1.4% | $45,795,575 |
| NOVO HOLDINGS A/S | 2.8% | 1,750,000 | +1.4% | 2.8% | $43,662,500 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8% | 1,734,743 | 0.01% | $43,281,838 | |
| Cormorant Asset Management, LP | 2.2% | 1,363,200 | -6.3% | 2.3% | $34,011,840 |
| Saturn V Capital Management LP | 1.4% | 886,332 | 4.8% | $22,113,983 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3% | 816,808 | +6.5% | 0% | $20,380,000 |
| 5AM Venture Management, LLC | 1.3% | 797,600 | 0% | 7.3% | $19,900,120 |
| Sofinnova Investments, Inc. | 1.2% | 739,876 | +26% | 1.1% | $18,459,906 |
| Octagon Capital Advisors LP | 1.2% | 722,595 | +7.4% | 2.8% | $18,028,745 |
| Kynam Capital Management, LP | 1.1% | 675,000 | 1.3% | $16,841,250 | |
| VR ADVISER, LLC | 1.1% | 674,599 | -67% | 0.95% | $16,831,245 |
| Soleus Capital Management, L.P. | 1% | 647,052 | -12% | 0.86% | $16,143,947 |
| Balyasny Asset Management L.P. | 1% | 625,758 | 0.03% | $15,612,662 | |
| Rock Springs Capital Management LP | 1% | 623,402 | 0% | 0.91% | $15,553,880 |
| Point72 Asset Management, L.P. | 0.83% | 519,381 | +1281% | 0.03% | $12,958,557 |
| BlackRock, Inc. | 0.67% | 414,417 | +106% | 0% | $10,339,704 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 20,182 | $560,051 | +$98,263 | $27.75 | 1 |
| 2025 Q3 | 57,844,608 | $1,443,142,875 | +$236,461,386 | $24.95 | 83 |
| 2025 Q2 | 45,040,180 | $792,712,813 | +$1,806,103 | $17.60 | 60 |
| 2025 Q1 | 44,939,067 | $705,543,867 | +$4,132,739 | $15.70 | 52 |
| 2024 Q4 | 44,644,168 | $855,824,077 | -$7,190,155 | $19.17 | 54 |
| 2024 Q3 | 45,045,428 | $834,243,398 | +$34,119,580 | $18.52 | 51 |
| 2024 Q2 | 43,008,763 | $808,565,649 | +$10,680,383 | $18.80 | 36 |
| 2024 Q1 | 42,425,740 | $980,459,437 | +$36,728,417 | $23.11 | 35 |
| 2023 Q4 | 40,745,703 | $1,142,917,292 | +$327,949,428 | $28.05 | 36 |
| 2023 Q3 | 29,067,102 | $606,630,419 | +$4,468,799 | $20.87 | 21 |
| 2023 Q2 | 28,913,752 | $441,577,880 | +$109,619,000 | $15.14 | 21 |
| 2023 Q1 | 21,781,494 | $173,888,454 | +$3,756,313 | $8.06 | 21 |
| 2022 Q4 | 21,301,855 | $239,644,411 | -$1,830,525 | $11.25 | 25 |
| 2022 Q3 | 22,314,954 | $173,600,000 | -$317,120 | $7.67 | 21 |
| 2022 Q2 | 22,353,338 | $494,009,000 | +$14,911,660 | $22.10 | 20 |
| 2022 Q1 | 21,685,388 | $397,090,000 | +$838,867 | $18.14 | 22 |
| 2021 Q4 | 21,647,018 | $321,068,000 | -$1,695,268 | $14.39 | 22 |
| 2021 Q3 | 21,631,638 | $380,302,000 | -$6,827,497 | $17.73 | 25 |
| 2021 Q2 | 21,995,815 | $406,288,000 | -$1,442,853 | $18.62 | 28 |
| 2021 Q1 | 22,025,122 | $616,507,000 | +$616,507,000 | $27.99 | 33 |